Melabest Cream is a topical formulation containing Hydroquinone (2% w/w), Mometasone Furoate (0.1% w/w), and Tretinoin (0.025% w/w), designed for the management of hyperpigmentation disorders such as melasma, post-inflammatory hyperpigmentation, and other pigmentary abnormalities. Hydroquinone acts as a depigmenting agent by inhibiting tyrosinase, thereby reducing melanin synthesis and promoting skin lightening. Mometasone Furoate, a potent corticosteroid, provides anti-inflammatory effects that help alleviate erythema and irritation associated with pigmentary conditions, while also enhancing the efficacy of hydroquinone by reducing inflammation-induced melanogenesis. Tretinoin, a retinoid, facilitates epidermal turnover and promotes the dispersion of melanin granules, improving skin texture and aiding in the penetration of hydroquinone. The combination of these active ingredients offers a synergistic approach to effectively lighten hyperpigmented lesions while minimizing inflammatory responses. Melabest Cream should be applied once daily to the affected areas as directed by a healthcare professional. Caution is advised due to potential side effects such as skin irritation, redness, and photosensitivity; therefore, concurrent use of sunscreen and avoidance of excessive sun exposure are recommended. This product is intended for external use only and should not be used during pregnancy or lactation without medical consultation.